F. Ariey, B. Witkowski, and C. Amaratunga, A molecular marker of artemisinin-resistant Plasmodium falciparum malaria, Nature, vol.10, issue.7481, pp.50-55, 2014.
DOI : 10.1038/nature12876
URL : https://hal.archives-ouvertes.fr/pasteur-00921203

E. Ashley, M. Dhorda, and R. Fairhurst, Malaria, New England Journal of Medicine, vol.371, issue.5, pp.411-434, 2014.
DOI : 10.1056/NEJMoa1314981
URL : https://hal.archives-ouvertes.fr/inserm-00854378

S. Takala-harrison, C. Jacob, and C. Arze, Independent Emergence of Artemisinin Resistance Mutations Among Plasmodium falciparum in Southeast Asia, Journal of Infectious Diseases, vol.211, issue.5, pp.670-79, 2015.
DOI : 10.1093/infdis/jiu491

A. Dondorp, F. Nosten, and P. Yi, Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-67, 2009.
DOI : 10.1056/NEJMoa0808859
URL : https://hal.archives-ouvertes.fr/hal-01199794

H. Noedl, Y. Se, and K. Schaecher, Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2639, 2008.
DOI : 10.1056/NEJMc0805011

C. Amaratunga, P. Lim, and S. Suon, Dihydroartemisinin???piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study, The Lancet Infectious Diseases, vol.16, issue.3, pp.357-65, 2016.
DOI : 10.1016/S1473-3099(15)00487-9

V. Duru, N. Khim, and R. Leang, Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations, BMC Medicine, vol.47, issue.3, p.305, 2015.
DOI : 10.1186/s12916-015-0539-5

R. Leang, W. Taylor, and D. Bouth, Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment, Antimicrobial Agents and Chemotherapy, vol.59, issue.8, pp.4719-4745, 2015.
DOI : 10.1128/AAC.00835-15

M. Spring, J. Lin, and J. Manning, Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study, The Lancet Infectious Diseases, vol.15, issue.6, pp.683-91, 2015.
DOI : 10.1016/S1473-3099(15)70049-6

R. Leang, A. Barrette, and D. Bouth, Efficacy of Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010, Antimicrobial Agents and Chemotherapy, vol.57, issue.2, pp.818-844, 2008.
DOI : 10.1128/AAC.00686-12

S. Cranmer, C. Magowan, J. Liang, R. Coppel, and B. Cooke, An alternative to serum for cultivation of Plasmodium falciparum in vitro, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.91, issue.3, pp.363-65, 1997.
DOI : 10.1016/S0035-9203(97)90110-3

J. Beghain, A. Langlois, and E. Legrand, Plasmodium copy number variation scan: gene copy numbers evaluation in haploid genomes, Malaria Journal, vol.419, issue.1, p.206, 2016.
DOI : 10.1186/s12936-016-1258-x
URL : https://hal.archives-ouvertes.fr/pasteur-01303621

S. Wang, D. Dvorkin, Y. Da, N. Dharia, E. Winzeler et al., SNPEVG: a graphical tool for GWAS graphing with mouse clicks Piperaquine resistance is associated with a copy number variation on chromosome 5 in drug-pressured Plasmodium falciparum parasites, BMC Bioinformatics Antimicrob Agents Chemother, vol.13, issue.55, pp.319-3908, 2011.

M. Veiga, S. Dhingra, and P. Henrich, Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies, Nature Communications, vol.54, p.11553, 2016.
DOI : 10.1038/ncomms11553

A. Cowman, D. Galatis, and J. Thompson, Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine., Proceedings of the National Academy of Sciences, vol.91, issue.3, pp.1143-1190, 1994.
DOI : 10.1073/pnas.91.3.1143

R. Price, A. Uhlemann, and A. Brockman, Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number, The Lancet, vol.364, issue.9432, pp.438-485, 2004.
DOI : 10.1016/S0140-6736(04)16767-6

A. Sidhu, A. Uhlemann, S. Valderramos, J. Valderramos, S. Krishna et al., Malaria Heightens Susceptibility to Mefloquine, Lumefantrine, Halofantrine, Quinine, and Artemisinin, The Journal of Infectious Diseases, vol.194, issue.4, pp.528-563, 2006.
DOI : 10.1086/507115

S. Nair, D. Nash, and D. Sudimack, Recurrent Gene Amplification and Soft Selective Sweeps during Evolution of Multidrug Resistance in Malaria Parasites, Molecular Biology and Evolution, vol.24, issue.2, pp.562-73, 2007.
DOI : 10.1093/molbev/msl185

P. Lim, D. Dek, V. Try, S. Sreng, S. Suon et al., Susceptibility to Mefloquine, Antimicrobial Agents and Chemotherapy, vol.59, issue.5, pp.2934-2971, 2015.
DOI : 10.1128/AAC.05163-14

J. Bonilla, P. Moura, T. Bonilla, C. Yowell, D. Fidock et al., Eff ects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum

N. Sachanonta, K. Chotivanich, and U. Chaisri, -infected Red Blood Cells Following Treatment with Antimalarial Drugs, Ultrastructural Pathology, vol.57, issue.5, pp.214-239, 2011.
DOI : 10.1016/S0020-7519(02)00194-7

P. Rohrbach, C. Sanchez, and K. Hayton, Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum, The EMBO Journal, vol.3, issue.13, pp.3000-3011, 2006.
DOI : 10.1073/pnas.82.9.2784

C. Sanchez, A. Rotmann, W. Stein, and M. Lanzer, Polymorphisms within PfMDR1 alter the substrate specifi city for anti-malarial drugs in Plasmodium falciparum, Mol Microbiol, vol.70, pp.786-98, 2008.

O. Miotto, J. Almagro-garcia, and M. Manske, Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia, Nature Genetics, vol.89, issue.6, pp.648-55, 2013.
DOI : 10.1101/gr.094052.109

N. Valecha, S. Krudsood, and N. Tangpukdee, Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial, Clinical Infectious Diseases, vol.55, issue.5, pp.663-71, 2012.
DOI : 10.1093/cid/cis475